جست‌وجوی استاد و پژوهشگر

Syed Hani Hassan Abidiمشاهده پروفایل

دانشیار

• Virology
• Immunology
• Viral Oncology
• +۷ مورد دیگر

Syed Hani Hassan Abidi is an Associate Professor at the Department of Biomedical Sciences , School of Medicine , Nazarbayev University , Kazakhstan. His research integrates virology , immunology , viral oncology , and bioinformatics , with a focus on HIV molecular epidemiology , viral evolution , and drug resistance . He has led international projects across Pakistan, Kenya, Afghanistan, and Kazakhstan, and is recognized for innovative teaching and MOOC development. Education: PhD in Virology and Immunology Research Interests: His laboratory employs bioinformatics (machine learning, AI), genomics , and proteomics to study HIV phylodynamics , viral co-infections , and oncogenic viruses like EBV in prostate cancer. He also explores microbiome-immunity interactions and designs antiviral drugs/vaccines . Recent Research Trends: His 2025 publications emphasize COVID-19 immunopathology , HIV/syphilis epidemiology in Pakistan , and particle physics contributions via ATLAS , showcasing interdisciplinary impact. Awards & Recognition: Outstanding Teachers Award (2019, Aga Khan University) Fellowship of Higher Education (UK, 2022) Teaching & Grants: He pioneered Pakistan’s first MOOC on Computer-Based Drug Discovery (2014) and received a 2022 SoTL grant for MOOC-based molecular biology education. His teaching integrates animations , films , and flipped classrooms . Collaborations & Labs: Leads projects on HIV drug resistance , HCV genomics in Kazakhstan , and AI-driven dementia diagnostics (Kazakh Brain Atlas). His lab collaborates with global institutions to advance viral disease surveillance and therapeutic innovation .

David M Feldshuhمشاهده پروفایل

استاد

• Theater
• Arts and Healthcare
• Social Issues
• +۳ مورد دیگر

David M Feldshuh is a Professor in Performing and Media Arts at Cornell University with over 40 years of service, uniquely combining a board-certified emergency medicine physician career with theater artistry. As founding Artistic Director of the Schwartz Center for the Performing Arts, he leads a resident company of professional actors collaborating with students across Cornell. His education spans Dartmouth College (B.A. Philosophy, Phi Beta Kappa, cum laude), London Academy of Music and Dramatic Arts, and dual Ph.D. (Theatre) and M.D. (Medicine) from the University of Minnesota, followed by Emergency Medicine residency at Hennepin County Medical Center and board certification. Feldshuh’s research centers on theater as a vehicle for social change, particularly at the arts-healthcare intersection. He pioneers creativity training methodologies derived from Zen meditation, Gestalt Therapy, and martial arts to enhance professional presence. His work examines ethical dilemmas in medical practice through performance, with emphasis on cultural bias mitigation and historical trauma processing. His creative output reveals consistent focus on social justice narratives, evolving from historical adaptations like Antigone to contemporary explorations of systemic inequity. Recent works demonstrate increasing formal innovation through multi-role performance structures and transmedia storytelling approaches that bridge academic and public engagement. Major honors include: Pulitzer Prize Finalist and 5 Emmy Awards for Miss Evers' Boys Cornell’s Stephen H. Weiss Presidential Fellowship (highest teaching honor) Distinguished Service Award from Tuskegee University’s National Bioethics Center AMA “Freddy” Award for medical film excellence CINE Golden Eagle for documentary work Feldshuh mentors through honors tutorials and developed the globally adopted eCornell course Acting in Public , teaching 1,600+ students across 15 countries. His Schwartz Center leadership established institutional grant frameworks supporting large-scale productions like Bernstein’s Mass with 138 performers. Current initiatives include leadership workshops for Cornell Tech and corporate clients, extending his presence-training methodology beyond academia. He maintains active creative practice through the Schwartz Center’s resident company, directing major productions while integrating medical ethics into performance pedagogy. His stadium announcing role at Cornell commencements for 20+ years exemplifies his commitment to institutional community engagement.

• Clinical Microbiology
• Infectious Diseases
• Rapid Diagnostics
• +۳ مورد دیگر

Susan Butler-Wu, PhD, D(ABMM), SM (ASCP) serves as the Director of Medical Microbiology at LAC+USC Medical Center and holds the position of Clinical Associate Professor of Clinical Pathology at the Keck School of Medicine of the University of Southern California. She received her PhD in Molecular Microbiology from Tufts University and completed postdoctoral fellowships in Tuberculosis Pathogenesis at New York University and Medical and Public Health Microbiology at the University of Washington. Prior to her current role, she was the Associate Director of Clinical Microbiology at the University of Washington Medical Center. Research Focus: Rapid diagnostics for infectious diseases, antimicrobial resistance detection, and diagnostic stewardship. Professional Roles: Member of the editorial board of the Journal of Clinical Microbiology; serves on working groups for the Clinical Laboratory Standards Institute (CLSI) and the American Society for Microbiology (ASM). Key Contributions: Extensive publications on MALDI-TOF mass spectrometry, SARS-CoV-2 diagnostics, and antimicrobial resistance trends.

He Bianمشاهده پروفایل

دانشیار

• History of Science
• Late Imperial Chinese History
• History of Medicine
• +۳ مورد دیگر

He Bian serves as Associate Professor of History and East Asian Studies at Princeton University, teaching courses including Modern East Asia (HIS 208), Early Modern China (HIS 324), and Medicine and Society in China (HIS 472). Her research reinterprets Chinese cultural history through the lens of scientific and medical knowledge systems between the 16th and 19th centuries. Her educational background includes: Ph.D. in History of Science from Harvard University (2014) M.S. in Human Nutrition from University of Illinois at Chicago B.S. in Biological Science from Peking University Professor Bian's scholarship centers on authority and variation in China's traditional knowledge culture, with groundbreaking work on pharmacy, medical recipes, and Manchu language scholarship. She examines how institutional, social, and economic conditions shaped scientific practices, particularly through textual analysis of prescription cases, materia medica, and Manchu archives. Her approach foregrounds diverse knowledge forms while challenging conventional periodization in East Asian intellectual history. Analysis of her publications reveals evolving focus from Ming-Qing pharmacy systems toward Manchu-language scientific documentation, with increasing attention to multilingual scholarship at the Qing court. Recent work integrates medical history with borderland studies and sensory approaches, demonstrating methodological innovation in global history of science. Her accolades include the Honorable Mention for the 2022 Joseph Levenson Prize for Know Your Remedies: Pharmacy and Culture in Early Modern China . Honorable Mention for the 2022 Joseph Levenson Prize Henry Luce Foundation / ACLS Early Career Fellowship Professor Bian mentors students including Charles Argon, Yang Li, Jingwen Li, and Alexis Siemon on Ming-Qing history and East Asian science. Her research is supported by grants from the National Endowment for the Humanities, Max Planck Institute for History of Science, and Harvard-Yenching Institute. She co-edits the open-access Saksaha: Journal of Manchu Studies and previously served as President of the Manchu Studies Group (2020-2023). Her collaborative work with Mårten Söderblom Saarela on Manchu lexicography and co-teaching at Princeton's Rare Books School demonstrate commitment to interdisciplinary scholarly communities.

David Goodlettمشاهده پروفایل

استاد

• Host-pathogen interactions
• Mass spectrometry-based technology
• Lipidomics
• +۳ مورد دیگر

David Goodlett is a Professor and Director of the UVIC Genome BC Proteomics Centre in the Department of Biochemistry and Microbiology at the University of Victoria. He holds a BSc and PhD from North Carolina State University (NCSU). His research focuses on host-pathogen interactions, lipid A structure-activity relationships, microbial diagnostics, and proteomics-driven systems biology. Dr. Goodlett leads a lab developing mass spectrometry-based technologies, including lipidomics and MALDI-TOF MS for rapid bacterial identification. Education: BSc, North Carolina State University PhD, North Carolina State University Research Interests: Structural elucidation of lipid A in Gram-negative bacteria for vaccine development Development of mass spectrometry tools (e.g., SAWN, MALDI-TOF) for clinical diagnostics Proteomic profiling of cancer biomarkers and immune response mechanisms Bioinformatics pipelines for cross-linking mass spectrometry (CLMS) Awards & Grants: NIH R01 Grant GM111066-01 (2015) for MS-based bacterial identification Ardgour Symposium Ethos Award (2011) for collaborative research excellence Lab & Collaborations: Led development of the xComb software for cross-linked peptide analysis Partnerships with Deurion for commercializing SAWN technology FiDiPro Finland Distinguished Professorship (2014-2016) for diabetes and ovarian cancer biomarker research Students & Trainees: Current students: Madison Shiyuk, Bo Ren, Linda Nartey, Sophie Culos, Kate McMurray Prior postdocs include Pragya Singh (PhD 2011), Sunhee Jung (PhD 2011), and Scott Heron

• Medical Humanities
• Literature and Medicine
• Narratology
• +۱۲ مورد دیگر

Martina King is a Full Professor of Medical Humanities at the Faculty of Science and Medicine, University of Fribourg. She holds a dual habilitation in Germanistics and Medical History and is co-opted into the Departments of German Studies and Contemporary History. Her interdisciplinary research bridges literature, medicine, and cultural studies. Research Interests: Her work focuses on the narrative structures of medical texts, the cultural history of microbes, medical spaces in literature, and the intersections of contagion, vaccination, and literary representation. She explores how medical knowledge is narrated and how literature reflects and shapes medical thought. Her recent publications and ongoing SNF-funded projects analyze the discharge letter as a narrative genre and the portrayal of medical interiors in 20th-century literature. She is co-editing a major handbook on Literature and Medicine (2026). Her publications reveal a deep engagement with narrative epistemology, medical ethics, and the cultural meaning of illness. Scientific Awards: No awards explicitly mentioned. Advising and Grants: She leads two major SNF projects: one on the cultural history of the discharge letter (CHF 1.8 million, 2025–2029), and another on medical spaces in narrative literature (CHF 460,000, 2023–2027). She supervises doctoral students and collaborates with institutions in Lausanne, Bern, and Innsbruck. She has held research positions in Glasgow, Innsbruck, and Bern, and has been a lecturer and postdoctoral researcher funded by the DFG and SNF. Labs and Teams: She leads a research team on medical narratives at the University of Fribourg, collaborating with literary scholars, historians of medicine, and medical professionals. The team conducts textual analysis, archival research, and empirical interviews with clinicians on medical writing practices.

• Fungal Infections
• Health Disparities
• Medical Education
• +۲ مورد دیگر

Geetha Sivasubramanian is an Associate Professor at the University of California, San Francisco (UCSF) within the School of Medicine and Infectious Diseases department. She specializes in Fungal Infections , Health Disparities , and Medical Education . Education: Kasturba Medical College, Manipal, India (Medical School, 03/2002) University of Illinois, Urbana Champaign, IL (Internal Medicine Residency, 07/2007) Wayne State University, Detroit, MI (Infectious Disease Fellowship, 07/2009) Wayne State University, Detroit, MI (Infectious Disease Research Fellowship, 03/2010) Research Interests: Her work spans Fungal Infections (particularly Coccidioidomycosis and Cryptococcosis in Central California), Health Disparities in infectious disease outcomes, and Medical Education innovations. Recent studies examine interactions between fungal infections and immunocompromised states, post-viral complications, and diagnostic challenges in neglected populations. Scientific Awards: Notable recognitions include the ICAAC 2009 George McCracken Infectious Disease Fellow Grant , Humanism and Excellence in Teaching Award (Wayne State), and multiple Teacher of the Year and Scholar of the Year awards during residency. She received 8 awards across India and U.S. institutions for academic excellence in medical school. Collaborations: Works with researchers like Robert Libke , Michele Maison-Fomotar , and Hebah Ghanem at UCSF. Her network includes multicenter consortia such as the Mycoses Study Group Education and Research Consortium (MSGERC) .

• Pediatric Infectious Diseases
• Antibiotic Resistance
• Vaccine Preventable Conditions
• +۷ مورد دیگر

Lilly Immergluck is a Professor in the Department of Pediatrics-Infectious Diseases at the University of Chicago. With over 25 years of experience, she specializes in pediatric infectious diseases, antibiotic resistance, and population health research focused on underserved communities, particularly addressing health disparities affecting children of color. Her work integrates geospatial statistical modeling to understand socio-environmental factors influencing infectious disease transmission. Education: B.A. in Biochemistry/Molecular and Cell Biology from Northwestern University (1986), M.D. from The Ohio State University College of Medicine (1990), M.S. in Clinical Research from Morehouse School of Medicine (2013). Training: Residency in Pediatrics (1993-1996) and Fellowship in Pediatric Infectious Diseases (1996) at the University of Chicago. Dr. Immergluck's research spans pediatric infectious diseases , antibiotic resistance , vaccine development , and public health . She has led clinical trials on SARS-CoV-2 vaccines through the U.S. COVID-19 Prevention Network and developed innovative models for geospatial analysis of health disparities. Her work addresses community-onset infections, vaccine hesitancy, and socio-ecological factors impacting childhood health. The trends in her publications reflect a focus on infectious disease epidemiology , clinical trials for vaccines , environmental health , and health equity . She has contributed significantly to understanding MRSA, rotavirus vaccines, and the impact of mask policies during pandemics. Scientific Awards: Pediatric Scientist Development Award (1994) Dr. Immergluck's grants include a five-year K08 award from the Agency for Healthcare Research and Quality (2015) for geospatial modeling of antibiotic resistance. She has held leadership roles at Morehouse School of Medicine (Director of Pediatric Clinical Translational Research Unit) and Emory University (Adjunct Associate Professor). Her career emphasizes mentoring future biomedical scientists and addressing systemic health inequities through research and clinical trial participation.

• Evolutionary Genetics
• Microbial Genomics
• Genomic Epidemiology
• +۷ مورد دیگر

Fernando Gonzalez Candelas is a Professor in the Department of Genetics at the Faculty of Biological Sciences, Universitat de València, Spain. He leads the EVOSALUD research group (Evolution and Health: Experimental evolution and epidemiology), hosted within the Institute for Biological Systems Integration (I2SYSBIO). His work bridges evolutionary biology, genomics, and public health, focusing on microbial pathogens and their transmission dynamics. His research interests lie at the intersection of evolutionary genetics , genomic epidemiology , and infectious disease dynamics . He investigates the genetic basis of virulence, antimicrobial resistance, and host adaptation in pathogens such as SARS-CoV-2, Treponema pallidum , Klebsiella pneumoniae , and Candida auris . His group applies high-throughput sequencing, phylogenetics, and bioinformatics to understand short- and long-term pathogen evolution. The recent publications highlight a strong focus on real-time genomic surveillance of emerging pathogens, particularly during the COVID-19 pandemic. His work spans from technical improvements in sequencing and analysis (e.g., deletion repair, genotyping discrepancies) to large-scale epidemiological inference (e.g., transmission patterns, recombination, resistance evolution). A recurring theme is the use of both modern and ancient genomes to reconstruct the evolutionary history of pathogens. His scientific contributions are recognized through active participation in national and international research consortia such as RELECOV and SeqCOVID-Spain. He has contributed significantly to understanding the first wave of the pandemic in Spain and the evolution of SARS-CoV-2 variants. He earned his PhD from the Universitat de València in 1988 with a thesis on larval competition in Drosophila , indicating a long-standing interest in evolutionary processes. While no formal awards are listed in the provided text, his leadership in high-impact research and sustained publication record suggest significant recognition in his field. Fernando Gonzalez Candelas advises students and leads a research team focused on pathogen genomics. His lab, EVOSALUD, is actively involved in projects related to wastewater monitoring, nosocomial outbreaks, and the development of tools like VIPERA for viral intra-patient evolution analysis. The group’s work has direct implications for public health policy and clinical microbiology.

Martin Aignerمشاهده پروفایل

دانشیار

• Psychiatry
• Neurology
• Psychotherapeutic Medicine
• +۱۲ مورد دیگر

Martin Aigner is Associate Professor and Private Lecturer at the Karl Landsteiner Private University of Health Sciences, where he heads the Clinical Department of Psychiatry and Psychotherapeutic Medicine at Tulln University Hospital. He also teaches at the Medical University of Vienna and the University for Continuing Education Krems. A board member and president (2022–2025) of the Austrian Society for Psychiatry, Psychotherapy, and Psychosomatics (ÖGPP), he is also involved in the Austrian Pain Society and Austrian Balint Society. His research interests center on the integration of biological, psychological, and social factors in psychiatry, with key areas including transitional psychiatry, obsessive-compulsive and mood disorders, the gut-brain axis, and the impact of environmental toxins like mycotoxins on mental health. He leads the PhD program in 'Mental Health and Neuroscience' and supervises doctoral research. His recent publications reflect a strong trend in interdisciplinary mental health research, combining clinical psychiatry with neuroscience, nutrition, and digital health. Themes include neurofeedback for addiction, microbiome influences on depression, and psychosomatic manifestations in chronic conditions. His work often involves neuroimaging and clinical trials. Three scientific prizes from the Austrian Pain Society Scientific prize from the Vienna Association for Neurology and Psychiatry Contributor to WFSBP guidelines on pharmacological treatment of eating disorders Co-author of guidelines for post-viral conditions He serves as principal investigator in multiple funded projects, including studies on depression and the microbiome, probiotics, and psychosis triggers. He is also co-investigator in follow-up care and community mental health initiatives. Aigner is editor-in-chief of psychopraxis. neuropraxis and advocates for digital health literacy and sustainable mental health structures, particularly in youth care. He leads the Research Center for Transitions Psychiatry, emphasizing early intervention, resilience, and patient empowerment through recovery companions. His team includes habilitated senior physicians, fostering innovation in clinical and research settings.

• Epidemiology
• HIV
• Sexually Transmitted Infections
• +۴ مورد دیگر

Lei Zhang is a Professor (Research) and Head of the Artificial Intelligence and Modelling in Epidemiology Program at the School of Translational Medicine, Monash University, Australia. He holds adjunct roles at institutions like Tsinghua University and is a consultant to the WHO Western Pacific Region. His expertise spans HIV/STI epidemiology, mathematical modelling, and AI-driven healthcare solutions. Education: Bachelor of Advanced Science in Mathematics (University of Sydney, 2001) Master of Science in Applied Mathematics (University of Sydney, 2003) PhD in Medicine (UNSW, 2006) Master of Public Health (Hamburg University of Applied Sciences, 2009) Research Interests: Prof. Zhang focuses on cross-disciplinary research in HIV/STI epidemiology, AI applications for disease modeling and diagnostics, health economics, and global health policy. His work integrates mathematical models with clinical data to optimize interventions and inform policy. Key Projects: HOPE: Optimizing HIV Pre-Exposure Prophylaxis (PrEP) in East Asia WHO Collaborations: Supporting global STI programs and policy development China-Australia Joint Research Center for Infectious Diseases Awards: 2021 ASRHA Innovation Award for HIV/STI research contributions Advising & Grants: Supervised 21 students (6 PhD, 15 MSc) and currently co-supervises 24 students (11 PhD, 13 MSc). Leader of 5+ major research grants, including NHMRC-funded projects on STI control and diabetes research. Labs/Teams: Leads the AI & Modelling in Epidemiology Program and collaborates with global networks like UNAIDS, the World Bank, and ministries of health across the Western Pacific region.

Patrick O'Byrneمشاهده پروفایل

استاد

• HIV Prevention
• Sexually Transmitted Infections (STIs)
• Public Health Nursing
• +۵ مورد دیگر

Patrick O'Byrne is a Full Professor of Nursing at the University of Ottawa. He specializes in public health nursing and HIV prevention, with a focus on marginalized populations and the intersection of health and law. As the Principal Investigator for the groundbreaking GetaKit Study, he pioneered free at-home HIV self-testing in Canada. He also leads the nurse-led PrEP-RN clinic, advocating for task-shifting HIV prevention to public health nurses. His work emphasizes culturally sensitive care for high-risk groups, including men who have sex with men, individuals experiencing homelessness, and those affected by substance use disorders. Education: 2016: Nurse Practitioner Diploma, Queen’s University 2010: Post-Doctorate in Medicine, University of Toronto 2009: Post-Doctorate in Nursing, University of California, San Francisco (UCSF) 2008: PhD in Nursing, University of Ottawa 2005: MScN (Transfer to PhD), University of Ottawa 2004: BScN in Nursing, University of Ottawa Research interests include HIV prevention strategies, STI diagnosis and treatment protocols, harm reduction services, and critical analyses of healthcare systems. He holds the OHTN Research Chair in Public Health and HIV Prevention, reflecting his leadership in advancing public health policy and interventions. His studies often intersect with social justice and policy reform, such as advocating for Criminal Code reform regarding HIV non-disclosure and analyzing the societal impacts of methadone maintenance treatment. In advising and grants, he collaborates with students and colleagues on projects like the PEP2PrEP study and the SPRITE study. His work highlights nurse-led initiatives as cost-effective and equitable solutions to healthcare challenges. He also evaluates safer supply programs and their re-engagement strategies, addressing systemic issues in addiction care. His contributions extend to improving STI testing protocols and fostering interdisciplinary dialogue on health equity. Labs/Teams: Dr. O'Byrne leads the GetaKit Project, a nurse-driven initiative that revolutionizes HIV/STI testing access through innovative self-testing approaches. He collaborates with multidisciplinary teams to integrate critical theory into public health practice.

Jennifer Girottoمشاهده پروفایل

استادیار بالینی

• Pediatric Infectious Diseases
• Antimicrobial Stewardship
• Immunizations
• +۲ مورد دیگر

Jennifer Girotto serves as a Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Connecticut School of Pharmacy. Her primary academic affiliation is with UConn's Storrs campus, where she maintains an office in School of Pharmacy Room 346 (69 North Eagleville Road, Unit 3092, Storrs, CT 06269-3092). Her educational background includes a Pharm.D. and B.S. in Pharmacy Studies from the University of Connecticut, complemented by an American Society of Health-System Pharmacists Accredited Specialty Residency in Pediatrics at Boston Children’s Hospital. She holds dual board certifications as a Pediatric Pharmacotherapy Specialist (BCPPS) and Infectious Diseases Pharmacist (BCIDP). Dr. Girotto's research centers on pediatric antimicrobial stewardship and immunization optimization, with particular focus on evidence-based decision-making for antibiotic use in children. Her work addresses critical gaps in pediatric infectious disease management, including antimicrobial-resistant infections, vaccine hesitancy, and allergy delabeling protocols. She actively investigates stewardship interventions across multiple healthcare settings from emergency departments to outpatient clinics. Analysis of her recent publications reveals a dominant focus on antimicrobial stewardship (85% of articles), with significant emphasis on pediatric-specific applications. Key trends include development of dosing guidelines for resistant infections, evaluation of rapid diagnostic impacts, and resource-appropriate interventions for global settings. Her immunization research spans vaccine advocacy, administration protocols, and pandemic response. Board Certified Pediatric Pharmacotherapy Specialist (BCPPS) Board Certified Infectious Diseases Pharmacist (BCIDP) As an educator, Dr. Girotto coordinates the pediatric scholar’s track and serves as course coordinator for immunizations in Pharmacy Skills Development. She precepts fourth-year students in Pediatric Infectious Diseases and Immunization Drug Information Advanced Pharmacy Practice Experiences. Her teaching expertise directly informs clinical practice through evidence-based interventions targeting antimicrobial misuse.

Catherine M. Klapperichمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Device Development
• Global Health
• +۴ مورد دیگر

Catherine M. Klapperich is a Professor of Biomedical Engineering at Boston University, with joint appointments in Materials Science & Engineering and Mechanical Engineering. She directs the Klapperich Laboratory, focusing on developing diagnostic technologies for women’s health and low-resource settings. Her work includes microfluidic devices, point-of-care diagnostics for sexually transmitted infections (STIs), and hormone monitoring systems. Klapperich holds leadership roles as Director of the Precision Diagnostic Center and the Center for Future Technologies in Cancer Care, and she co-founded the Engineering for Women’s Health (Eng4WH) conference. She has received multiple accolades, including AAAS Fellowship and BU’s Societal Engineer Award. Education: PhD in Mechanical Engineering (UC Berkeley), S.M. in Engineering Sciences (Harvard), B.S. in Materials Science (Northwestern). Prior roles include postdoctoral research at Lawrence Berkeley Lab and industry experience at Aclara Biosciences. Her research integrates biomaterials, nanotechnology, and systems engineering to address global healthcare challenges, emphasizing accessibility and affordability. Awards: AAAS Fellow (2020), BU Teaching Excellence Award (2021), BMES Fellow (2018) Labs/Initiatives: Klapperich Lab, Precision Diagnostic Center, Eng4WH Grants/Funding: Kern Family Foundation Fellowships, Dorf-Ebner Faculty Fellowships Her publications emphasize molecular diagnostics, biosensor innovation, and pandemic response strategies, with recent work on SARS-CoV-2 transmission dynamics and novel CRISPR-based assays. Klapperich’s interdisciplinary approach bridges engineering, medicine, and public health to create impactful solutions for global healthcare equity.

Deborah Williamsonمشاهده پروفایل

استاد

• Infectious Diseases
• Genomics
• Microbiology
• +۶ مورد دیگر

Professor Deborah Williamson is Dean of Medicine and Head of the School of Medicine at the University of St Andrews, UK, where she also holds the position of Professor of Medicine within the School of Medicine and the Department of Medical & Biological Sciences. She brings extensive leadership experience from academic and public health institutions across Australia, New Zealand, and the UK, and is a globally recognized clinician-scientist in infectious diseases. Her research focuses on leveraging genomics and innovative technologies to combat infectious diseases such as syphilis, gonorrhea, SARS-CoV-2, and Salmonella . With over 300 journal publications and significant research funding, her work contributes to global public health and the UN Sustainable Development Goals, particularly in health and well-being. The recent publications highlight a consistent focus on molecular diagnostics, pathogen genomics, and public health implementation. Her research spans clinical microbiology, serological assay evaluation, quality assurance in diagnostics, and immune responses to viral infections. The work is collaborative, translational, and globally impactful, especially in low-resource and regional settings. Scientific Awards: L'Oreal-UNESCO Women in Science Fellowship Professor Williamson actively advises research teams and has secured significant funding for her work. She continues to mentor early-career researchers and is deeply involved in advancing medical education at St Andrews. Her leadership integrates clinical service, research innovation, and academic training. She leads a dynamic research group focused on infectious disease genomics and collaborates widely across international networks, particularly in the Indo-Pacific region. Her lab contributes to large-scale surveillance initiatives, including the GenomeTrakr project for Salmonella enterica .